Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1033

1.

Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study.

Ogata M, Satake H, Ama Y, Hirabatake M, Ogata T, Yasui H, Hashida T.

Ann Oncol. 2019 Jul;30 Suppl 4:iv45. doi: 10.1093/annonc/mdz155.164. Epub 2019 Dec 4. No abstract available.

PMID:
32085168
2.

Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.

Tsuchiya K, Suzuki Y, Yoshimura K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T.

Sci Rep. 2020 Feb 19;10(1):3324. doi: 10.1038/s41598-020-58958-9.

3.

Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.

Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T.

Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906327. doi: 10.1177/1753466620906327.

PMID:
32046604
4.

Pre-treatment tumor size impacts on response to nivolumab in head and neck squamous cell carcinoma.

Inoue H, Yokota T, Hamauchi S, Onozawa Y, Kawakami T, Shirasu H, Notsu A, Yasui H, Onitsuka T.

Auris Nasus Larynx. 2020 Feb 5. pii: S0385-8146(20)30023-7. doi: 10.1016/j.anl.2020.01.003. [Epub ahead of print]

PMID:
32035695
5.
6.

Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.

Isobe Y, Sato K, Nishinaga Y, Takahashi K, Taki S, Yasui H, Shimizu M, Endo R, Koike C, Kuramoto N, Yukawa H, Nakamura S, Fukui T, Kawaguchi K, Chen-Yoshikawa TF, Baba Y, Hasegawa Y.

EBioMedicine. 2020 Jan 22;52:102632. doi: 10.1016/j.ebiom.2020.102632. [Epub ahead of print]

7.

Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.

Yoshihara M, Kajiyama H, Yokoi A, Sugiyama M, Koya Y, Yamakita Y, Liu W, Nakamura K, Moriyama Y, Yasui H, Suzuki S, Yamamoto Y, Ricciardelli C, Nawa A, Shibata K, Kikkawa F.

Int J Cancer. 2020 Apr 15;146(8):2268-2280. doi: 10.1002/ijc.32854. Epub 2020 Jan 24.

PMID:
31904865
8.

Suppressive Effects of Hot-water Extract of Magnolia obovata on Clostridium perfringens Enterotoxin-induced Cytotoxicity in Human Intestinal Caco-2 Cells.

Kawahara T, Fujii K, Nakajima K, Fujii R, Inagaki S, Hara K, Yasui H.

Planta Med. 2020 Feb;86(3):198-204. doi: 10.1055/a-1078-7860. Epub 2020 Jan 2.

PMID:
31896136
9.

Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies.

Furuta M, Watanabe J, Aramaki T, Notsu A, Yasui H.

In Vivo. 2020 Jan-Feb;34(1):275-282. doi: 10.21873/invivo.11771.

10.

Preclinical investigation of potential use of thymidine phosphorylase-targeting tracer for diagnosis of nonalcoholic steatohepatitis.

Higashikawa K, Horiguchi S, Tarisawa M, Shibata Y, Ohkura K, Yasui H, Takeda H, Kuge Y.

Nucl Med Biol. 2019 Dec 16;82-83:25-32. doi: 10.1016/j.nucmedbio.2019.12.006. [Epub ahead of print]

PMID:
31869736
11.

The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis.

Ito T, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Ohgi K, Yasui H, Yamazaki K, Uesaka K.

World J Surg. 2019 Dec 12. doi: 10.1007/s00268-019-05326-y. [Epub ahead of print]

PMID:
31832703
12.

A simplified method for therapeutic drug monitoring of mitotane by gas chromatography-electron ionization-mass spectrometry.

Ando M, Hirabatake M, Yasui H, Fukushima S, Sugioka N, Hashida T.

Biomed Chromatogr. 2020 Mar;34(3):e4776. doi: 10.1002/bmc.4776. Epub 2020 Jan 28.

PMID:
31826297
13.

Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.

Tsuchiya K, Suzuki Y, Yoshimura K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T.

Sci Rep. 2019 Dec 10;9(1):18750. doi: 10.1038/s41598-019-55289-2. Erratum in: Sci Rep. 2020 Feb 19;10(1):3324.

14.

Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.

Shibata Y, Yasui H, Higashikawa K, Miyamoto N, Kuge Y.

PLoS One. 2019 Dec 4;14(12):e0225931. doi: 10.1371/journal.pone.0225931. eCollection 2019.

15.

Mitochondrial fission promotes radiation-induced increase in intracellular Ca2+ level leading to mitotic catastrophe in mouse breast cancer EMT6 cells.

Bo T, Yamamori T, Yamamoto K, Fujimoto M, Yasui H, Inanami O.

Biochem Biophys Res Commun. 2020 Jan 29;522(1):144-150. doi: 10.1016/j.bbrc.2019.11.027. Epub 2019 Nov 19.

PMID:
31757415
16.

The Development and Characterization of Near-Isogenic and Pyramided Lines Carrying Resistance Genes to Brown Planthopper with the Genetic Background of Japonica Rice (Oryza sativa L.).

Nguyen CD, Verdeprado H, Zita D, Sanada-Morimura S, Matsumura M, Virk PS, Brar DS, Horgan FG, Yasui H, Fujita D.

Plants (Basel). 2019 Nov 12;8(11). pii: E498. doi: 10.3390/plants8110498.

17.

Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.

Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Sumikawa H, Johkoh T, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.

Respir Med. 2019 Nov;159:105811. doi: 10.1016/j.rmed.2019.105811. Epub 2019 Nov 5.

PMID:
31710871
18.

Exfiltration and infiltration effect on sewage flow and quality: a case study of Hue, Vietnam.

Watanabe R, Harada H, Yasui H, Le TV, Fujii S.

Environ Technol. 2019 Oct 28:1-11. doi: 10.1080/09593330.2019.1680739. [Epub ahead of print]

PMID:
31657999
19.

High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.

Morita A, Aoshima K, Gulay KCM, Onishi S, Shibata Y, Yasui H, Kobayashi A, Kimura T.

Res Vet Sci. 2019 Dec;127:1-10. doi: 10.1016/j.rvsc.2019.09.011. Epub 2019 Oct 17.

PMID:
31648115
20.

Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.

Kimura H, Hamauchi S, Kawai S, Onozawa Y, Yasui H, Yamashita A, Ogawa H, Onoe T, Kamijo T, Iida Y, Onitsuka T, Yokota T.

Int J Clin Oncol. 2020 Feb;25(2):258-266. doi: 10.1007/s10147-019-01560-5. Epub 2019 Oct 16.

PMID:
31620932
21.

Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.

Nozaki M, Yasui H, Ohnishi Y.

Cancers (Basel). 2019 Oct 14;11(10). pii: E1552. doi: 10.3390/cancers11101552.

22.

High-resolution mapping of GRH6, a gene from Oryza nivara (Sharma et Shastry) conferring resistance to green rice leafhopper (Nephotettix cincticeps Uhler).

Phi CN, Fujita D, Yamagata Y, Yoshimura A, Yasui H.

Breed Sci. 2019 Sep;69(3):439-446. doi: 10.1270/jsbbs.19029. Epub 2019 Jun 27.

23.

Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.

Akiyama N, Hozumi H, Isayama T, Okada J, Sugiura K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.

Respirology. 2019 Oct 9. doi: 10.1111/resp.13707. [Epub ahead of print]

PMID:
31597225
24.

Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.

Furuhashi K, Fujisawa T, Hashimoto D, Kamiya Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T.

J Asthma Allergy. 2019 Sep 17;12:253-261. doi: 10.2147/JAA.S223093. eCollection 2019. Review.

25.

Identification of Anther Length QTL and Construction of Chromosome Segment Substitution Lines of Oryza longistaminata.

Ogami T, Yasui H, Yoshimura A, Yamagata Y.

Plants (Basel). 2019 Sep 29;8(10). pii: E388. doi: 10.3390/plants8100388.

26.

Perspectives on the Use of Ninjin'yoeito in Modern Medicine: A Review of Randomized Controlled Trials.

Takayama S, Arita R, Ohsawa M, Kikuchi A, Yasui H, Makino T, Motoo Y, Ishii T.

Evid Based Complement Alternat Med. 2019 Sep 2;2019:9590260. doi: 10.1155/2019/9590260. eCollection 2019. Review.

27.

Nucleoside analogs as a radiosensitizer modulating DNA repair, cell cycle checkpoints, and apoptosis.

Yasui H, Iizuka D, Hiraoka W, Kuwabara M, Matsuda A, Inanami O.

Nucleosides Nucleotides Nucleic Acids. 2019 Sep 27:1-14. doi: 10.1080/15257770.2019.1670839. [Epub ahead of print]

PMID:
31560250
28.

Pathological response measured using virtual microscopic slides for gastric cancer patients who underwent neoadjuvant chemotherapy.

Kawai S, Shimoda T, Nakajima T, Terashima M, Omae K, Machida N, Yasui H.

World J Gastroenterol. 2019 Sep 21;25(35):5334-5343. doi: 10.3748/wjg.v25.i35.5334.

29.

CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.

Yasui H, Kajiyama H, Tamauchi S, Suzuki S, Peng Y, Yoshikawa N, Sugiyama M, Nakamura K, Kikkawa F.

Clin Exp Metastasis. 2020 Feb;37(1):145-158. doi: 10.1007/s10585-019-09993-y. Epub 2019 Sep 21.

PMID:
31541326
30.

Identification and Characterization of the Pheromones in the Minute Pirate Bug Orius sauteri (Heteroptera: Anthocoridae).

Uehara T, Maeda T, Shimoda M, Fujiwara-Tsujii N, Yasui H.

J Chem Ecol. 2019 Oct;45(10):811-817. doi: 10.1007/s10886-019-01104-1. Epub 2019 Sep 7.

PMID:
31494780
31.

Development of introgression lines of AA genome Oryza species, O. glaberrima, O. rufipogon, and O. nivara, in the genetic background of O. sativa L. cv. Taichung 65.

Yamagata Y, Win KT, Miyazaki Y, Ogata C, Yasui H, Yoshimura A.

Breed Sci. 2019 Jun;69(2):359-363. doi: 10.1270/jsbbs.19002. Epub 2019 May 18.

32.

Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.

Kono M, Nakamura Y, Enomoto N, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Kobayashi T, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Inui N, Suda T, Nakamura H.

Respir Investig. 2019 Nov;57(6):552-560. doi: 10.1016/j.resinv.2019.07.003. Epub 2019 Aug 31.

PMID:
31477470
33.

Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.

Akahori D, Suzuki Y, Yokomura K, Shirai M, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Hayakawa H, Suda T.

J Infect. 2019 Oct;79(4):341-348. doi: 10.1016/j.jinf.2019.07.014. Epub 2019 Jul 31.

PMID:
31376456
34.

Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7.

Kikuchi J, Hori M, Iha H, Toyama-Sorimachi N, Hagiwara S, Kuroda Y, Koyama D, Izumi T, Yasui H, Suzuki A, Furukawa Y.

Leukemia. 2020 Jan;34(1):180-195. doi: 10.1038/s41375-019-0525-6. Epub 2019 Jul 29.

PMID:
31358854
35.

Antioxidant activity of proteins extracted from red alga dulse harvested in Japan.

Sato N, Furuta T, Takeda T, Miyabe Y, Ura K, Takagi Y, Yasui H, Kumagai Y, Kishimura H.

J Food Biochem. 2019 Feb;43(2):e12709. doi: 10.1111/jfbc.12709. Epub 2018 Oct 29.

PMID:
31353655
36.

Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.

Tsuchiya K, Karayama M, Sato T, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Sugimura H, Yasuda H, Suda T.

Intern Med. 2019 Nov 15;58(22):3299-3304. doi: 10.2169/internalmedicine.3004-19. Epub 2019 Jul 22.

37.

Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine.

Ogata M, Satake H, Ogata T, Hatachi Y, Hara S, Hirota S, Yasui H.

Intern Med. 2019 Nov 15;58(22):3243-3246. doi: 10.2169/internalmedicine.2806-19. Epub 2019 Jul 22.

38.

Minute Pulmonary Meningothelial-like Nodules Showing Multiple Ring-shaped Opacities.

Harada M, Aono Y, Yasui H, Uto T, Sato J, Imokawa S, Suzuki S, Tanioka F, Suda T.

Intern Med. 2019 Nov 1;58(21):3149-3152. doi: 10.2169/internalmedicine.2108-18. Epub 2019 Jul 22. Review.

39.

Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.

Enomoto N, Oyama Y, Yasui H, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.

Sci Rep. 2019 Jul 19;9(1):10484. doi: 10.1038/s41598-019-46990-3.

40.

Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.

Karayama M, Inui N, Yasui H, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T.

Int J Chron Obstruct Pulmon Dis. 2019 Jun 24;14:1333-1342. doi: 10.2147/COPD.S207267. eCollection 2019.

41.

Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.

Aoshima Y, Karayama M, Sagisaka S, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.

Intern Med. 2019 Nov 15;58(22):3267-3271. doi: 10.2169/internalmedicine.3032-19. Epub 2019 Jul 10.

42.

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18F]DiFA and comparison with [18F]FMISO.

Watanabe S, Shiga T, Hirata K, Magota K, Okamoto S, Toyonaga T, Higashikawa K, Yasui H, Kobayashi J, Nishijima KI, Iseki K, Matsumoto H, Kuge Y, Tamaki N.

EJNMMI Res. 2019 Jul 5;9(1):60. doi: 10.1186/s13550-019-0525-6.

43.

Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.

Arai H, Iwasa S, Boku N, Kawahira M, Yasui H, Masuishi T, Muro K, Minashi K, Hironaka S, Fukuda N, Takahari D, Nakajima TE.

BMC Cancer. 2019 Jul 3;19(1):652. doi: 10.1186/s12885-019-5720-3.

44.

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.

Cancer Sci. 2019 Sep;110(9):2875-2883. doi: 10.1111/cas.14117. Epub 2019 Jul 23.

45.

Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.

Katsumata M, Hozumi H, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.

Respir Med. 2019 Jul - Aug;154:102-108. doi: 10.1016/j.rmed.2019.06.016. Epub 2019 Jun 19.

PMID:
31229943
46.

Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.

Furuta M, Yokota T, Tsushima T, Todaka A, Machida N, Hamauchi S, Yamazaki K, Fukutomi A, Kawai S, Kawabata T, Onozawa Y, Yasui H.

Jpn J Clin Oncol. 2019 Oct 1;49(10):910-918. doi: 10.1093/jjco/hyz089.

PMID:
31219161
47.

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma.

Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A, Asanuma H, Tokita S, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nakae Y, Sugita O, Ito YM, Ota Y, Kimura Y, Kutomi G, Hirata K, Mizuguchi T, Imai K, Takemasa I, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2378-2385. doi: 10.1111/cas.14106. Epub 2019 Jul 23.

48.

Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series.

Kubo T, Tsurita G, Hirohashi Y, Yasui H, Ota Y, Watanabe K, Murai A, Matsuo K, Asanuma H, Shima H, Wada S, Nakatsugawa M, Kanaseki T, Tsukahara T, Mizuguchi T, Hirata K, Takemasa I, Imai K, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2386-2395. doi: 10.1111/cas.14099. Epub 2019 Jul 11.

49.

The Adjuvant Effect of Squalene, an Active Ingredient of Functional Foods, on Doxorubicin-Treated Allograft Mice.

Narayan Bhilwade H, Tatewaki N, Konishi T, Nishida M, Eitsuka T, Yasui H, Inanami O, Handa O, Naito Y, Ikekawa N, Nishida H.

Nutr Cancer. 2019;71(7):1153-1164. doi: 10.1080/01635581.2019.1597900. Epub 2019 Jun 10.

PMID:
31179755
50.

Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.

Horiike Y, Suzuki Y, Fujisawa T, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Ogawa N, Suda T.

Rheumatology (Oxford). 2019 Dec 1;58(12):2143-2152. doi: 10.1093/rheumatology/kez185.

PMID:
31143953

Supplemental Content

Support Center